1-2 of 2
Seiichi Sato, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mogamulizumab for ATLL in Clinical Practice

Masaaki Sekine, MD, Masaki Takeuchi, MD, Takanori Toyama, MD, Kouichi Maeda, MD, Seiichi Sato, MD, Kiyoshi Yamashita, MD, PhD, Junzo Ishizaki, MD, Akizuki Keiichi, MD, Ayako Kamiunten, MD, Takuro Kameda, MD PhD, Kotaro Shide, MD PhD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 2998.
https://doi.org/10.1182/blood.V128.22.2998.2998
Published: 2016
Journal Articles

Discontinuation Of Dasatinib In Patients With CML Who Have Maintained Complete Molecular Response For At Least One Year: Results From a Prospective Discontinuation (DADI) Trial

Hideo Tanaka, MD, PhD, Jun Imagawa, MD, PhD, Masaya Okada, MD, PhD, Hirohisa Nakamae, MD, PhD, Masayuki Hino, MD, PhD, Kazunori Murai, MD, PhD, Yoji Ishida, M.D., Ph.D., Takashi Kumagai, MD, PhD, Seiichi Sato, MD, Kazuteru Ohashi, MD, PhD, Hisashi Sakamaki, MD, PhD, Hisashi Wakita, MD, PhD, Nobuhiko Uoshima, MD, PhD, Yasunori Nakagawa, MD, Yosuke Minami, MD, PhD, Masahiro Ogasawara, MD, PhD, Tomoharu Takeoka, MD, Hiroshi Akasaka, MD, Satoshi Morita, PhD, Junichi Sakamoto, MD, PhD, Shinya Kimura, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3998.
https://doi.org/10.1182/blood.V122.21.3998.3998
Published: 2013